Trial Profile
Weight Based Enoxaparin for Venous Thromboembolism Prophylaxis in Trauma Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms WeBET
- 04 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 04 Apr 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
- 27 Jun 2016 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2016.